Powassan virus infection: case series and literature review from a single institution by Mihir Raval et al.
Raval et al. BMC Research Notes 2012, 5:594
http://www.biomedcentral.com/1756-0500/5/594CASE REPORT Open AccessPowassan virus infection: case series and
literature review from a single institution
Mihir Raval1,2*, Mayank Singhal1,2, Dubert Guerrero1,2 and Augusto Alonto1,2Abstract
Background: Powassan virus is a flavivirus related to eastern hemisphere’s tick-borne encephalitis viruses. It can
cause a rare but potentially life-threatening disease including encephalitis.
Case presentation: We report four cases of POWV infection in Minnesota and North Dakota with known exposure
to tick bites in 2011. Our first case was an 18-year-old male who dramatically presented with seizure and headache
with positive serum analysis for Powassan virus immunoglobulin M. The second case was a 60 year old gentleman
with intraparenchymal hemorrhage and was diagnosed via cerebrospinal fluid analysis. Thirdly, a 61 year old male
developed altered mental status and encephalitis. Our fourth patient was a 69 year old male who had headache
and non-focal weakness who was diagnosed with serum analysis.
Conclusion: Symptoms of Powassan virus infection ranged from headaches to seizures and severe neurological
symptoms. This study serves to highlight the increased detection of Powassan virus infection in the central north
United States. This report focuses on the increasing incidence that can lead to increasing efforts for raising
awareness regarding this infection. There is a need for clinician vigilance and public attention due to its increasing
detection, westward progression and varied clinical presentations.
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Powassan virus (POWV) was first isolated in 1958 and
since then, over 50 cases of Powassan virus (POWV)
reported between 1958 and 2011 [1-4]. Between 2000
and 2005, there were confirmed cases in northern cen-
tral United States including Michigan and Wisconsin
showing spread of disease westward [4,5]. Over the last
five years, there were only a total of 39 cases that have
been reported to Centers for Disease Control and Pre-
vention (CDC) [3].
We report a single institution experience of four cases
of POWV infection in 2011 from a teaching hospital in
North Dakota. This number is half of all cases from the
whole country reported to the CDC in the prior year
suggesting the need for public attention regarding the
disease in high identification area due to the potential* Correspondence: ravalmihir@gmail.com
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reproduction in any medium, provided the ormorbidity associated with the disease and lack of avail-
able treatment options [6].
Case presentation
Case 1
An 18-year-old male was evaluated in October of 2011
in northwestern Minnesota in consultation with neur-
ology service for a significant headache for two days and
one episode of seizure. He was at work, cutting trees,
and was suspended from a harness, where he suddenly
experienced clenching of his right upper extremity. He
then had a witnessed generalized convulsive seizure
while hanging in the air and required assistance to be
lowered to the ground. He had an associated headache,
with no meningismus. Computerized tomography scan
(CT scan) of the brain was unremarkable. Treatment
was deferred at that point, as it was a single isolated
seizure event. Subsequently he noticed worsening of his
headache. Magnetic Resonance Imaging (MRI) of the
brain was performed and was unremarkable. A lumbar
puncture (LP) was performed at outpatient neurology
clinic showing cerebrospinal fluid (CSF) protein oftd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 CT scan brain image of CASE 2 at initial presentation
in hospital showing acute intraparenchymal hemorrhage in the
frontal lobe area. This case suggests severity of presentation.
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66 mg/dL (N = 50-80 mg/dL), cell count -237 total
nucleated cells (4 red blood cells (N = 0-5), differential –
8% lymphocytes and 92% segmenters), and negative
herpes simplex virus (HSV)– polymerase chain reaction
(PCR). He subsequently developed right-sided weakness,
worsening headaches, and somnolence and was subse-
quently transferred to our facility to receive a higher level
of care. Upon transfer to our facility, it was then reported
that the patient had a tick bite. He was treated with anti-
biotics (ceftriaxone, vancomycin, ampicillin, acyclovir and
doxycycline which were later de-escalated based on infec-
tious work up). An electro encephalogram (EEG) per-
formed during hospitalization was normal and he had no
further witnessed seizures. Work-up for the more common
tick-borne infections including anaplasmosis/ehrlichiosis
(PCR and serology), lyme serology (non reactive), and
babesiosis PCR were unremarkable. West nile virus
(WNV) Immunoglobulin M (IgM) was negative. His initial
serum IgM and CSF IgM was negative (10/2011) for the
POWV but subsequent serum analysis (11/2011) was posi-
tive for POWV IgM by IgM antibody capture – enzyme
linked immunosorbent assay (MAC-EIA) method. He was
treated symptomatically. He gradually improved and was
discharged. During his follow up visit he did not report any
focal neurological deficits, seizures, or headaches.
Case 2
A 60-year old male who enjoys outdoor activity, with a
history of colon cancer (treated with hemicolectomy and
chemotherapy), diabetes mellitus and hypertension, pre-
sented to the emergency department with fevers, head-
aches and dizziness. His emergency department
examination was unremarkable for focal neurological
deficits, and he was discharged. Subsequently on his way
to pharmacy, he lost consciousness and was found
obtunded and unresponsive. He was intubated and
transferred to the intensive care unit (ICU). He was
afebrile upon admission. Initial evaluation included CT
scan of the brain that suggested intraparenchymal
hemorrhage with a subdural hematoma (Figure 1).
His laboratories were unremarkable except for pancyto-
penia with a white blood cell (WBC) count of 2.3 × 103/ul
(N = 4.5 – 11.0 × 103/ul), platelets of 81 × 103/ul (N =
150-450 × 103/ul) and hemoglobin of 10 g/dL (N = 13.5
-17.5 g/dL). Angiogram of the brain was unremarkable
for vascular anomaly. CSF analysis was not performed
due to multiple failed lumbar puncture attempts initially.
He was stabilized and subsequently extubated after
seven days. Upon transfer from the ICU, he did not
have focal neurological deficits, but was found to have
altered mental status, memory loss and anhedonia
with depression. Subsequently his long hospital stay was
complicated with central diabetes insipidus leading tohypernatremia that required vasopressin. He had a lum-
bar puncture on day 14 of hospitalization which revealed
xanthochromia (113 RBCs/ul) with total of 12 WBC/ul
which was predominantly lymphocytic (97%) and pro-
tein of 80 mg/dL (normal range (N) = 15-45 mg/dL), glu-
cose – 166 mg/dL (N = 50-80 mg/dL). Infectious work
up was negative for human immunodeficiency virus
(HIV) in blood, syphilis serum rapid plasma regain
(RPR), babesiosis serum PCR and peripheral smear,
WNV IgM in serum, anaplasmosis/ehrlichiosis serum
PCR and peripheral smear, varicella zoster virus CSF
PCR, HSV CSF PCR, lyme disease serum and CSF ser-
ology, enterovirus CSF PCR, California encephalitis virus
IgG and IgM [< 1:10 (N = < 1:10)], and Eastern equines
encephalitis antibody IgG and IgM [< 1:10 (N = < 1:10)].
CSF fluid was positive for immunoglobulin G (IgG) titers
of Saint Louis virus in high range (> = 1:40 with normal
range <1:10) and also IgM titer positive for POWV
detected via MAC-EIA (reported as detected IgM level
in Minnesota Department of Health (MN DOH) labora-
tory). The positive POWV IgM test was confirmed by
the National Institute of Infectious Diseases at CDC via
serum dilution plaque reduction neutralization test
(PRNT) suggesting titer of > 640 (Positive control results
> 640). He was treated symptomatically. His subsequent
imaging studies did not show any more progression of
intraparenchymal hemorrhages and subsequent im-
provement (Figures 2, 3). Patient was subsequently
transferred to a rehabilitation facility. His neurological
function recovered with return of his baseline functional
status on further follow up.
Figure 2 CT scan image of the brain of CASE 2 after 2 weeks of
initial presentation suggesting partial resolution of the
hemorrhage and no further progression or new hemorrhages
coinciding with the clinical improvement.
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A 61-year old male, from northwestern Minnesota,
with a history of diabetes mellitus, hypertension, pro-
gressive B cell lymphoma (multiple failed chemother-
apy and stem cell transplantation), presented with
progressive headaches, body aches, high-grade fever, and
altered mental status. He enjoyed outdoor activities and
reported frequent tick bites. Initial examination did notFigure 3 CT scan brain image of CASE 2 at 6 weeks of the
presentation showing significant resolution of the hemorrhage
with significant clinical improvement.reveal focal neurological deficits. CT scan of the brain
was unremarkable. Laboratory evaluation showed a
WBC count of 2.5 × 103/ul (N = 4.5 – 11.0 x103/ul).
Neoplastic involvement of central nervous system and
infection were possible differential diagnosis for which
an LP was performed. The initial CSF sample showed 3
WBC/ul, Protein 46 mg/dL (normal range (N) = 15-
45 mg/dL), glucose – 57 mg/dL (N = 50-80 mg/dL). CSF
was tested for HSV PCR Type 1/Type 2 (undetectable),
WNV IgG (Results < 1.30, positive - >1.49) and WNV
IgM (Result < 0.90, positive > 1.10), California encephal
itis virus IgG and IgM (Result < 1:16, positive - >1:16),
western equines encephalitis virus IgG and IgM (Result
< 1:16, positive - >1:16), eastern equines encephalitis
virus IgG and IgM (Result < 1:16, positive - >1:16), and
St. Louis encephalitis virus IgG and IgM (Result < 1:16,
positive - >1:16) The CSF sample was also checked
for paraneoplastic autoantibody panel and neoplastic
cells which were all negative. His fungal serology,
cytomegalovirus PCR, babesia PCR, mycoplasma IgM
screen, chlamydia serology, epstein-barr virus PCR and
urine histoplasma antigen assay, urine blastomyces
antigen, serum beta-D glucan (Value– 42 pg/ml – posi-
tive screen - >80 pg/ml) and sputum acid fast bacilli
assay were all negative. Patient was initially treated with
ceftriaxone, vancomycin and doxycycline. Lyme serology,
anaplasmosis and ehrlichiosis serologies were negative.
Due to clinical deterioration and hemodynamic instabil-
ity patient was transferred to our facility where he was
intubated and stabilized with mechanical ventilation.
MRI of the brain was unremarkable. Antibiotics were
changed to vancomycin, acyclovir, piperacillin/tazobac-
tam and micafungin. Another LP was performed (5 days
from initial LP). CSF was negative for coccidioidiomyco-
sis antibody –IgG/IgM, histoplasma – yeast/mycelium/
immunodiffusion, blastomycosis antibody by EIA, and
fungal culture. The CSF was also sent to the Minnesota
department of health (MN DOH) for POWV study. Pal-
liative care was subsequently initiated due to lack of pa-
tient improvement initially and underlying lymphoma.
Three weeks after his discharge to palliative care, his CSF
(Second LP) was positive by PCR. He was eventually
diagnosed with POWV encephalitis. Patient stayed in re-
habilitation facility for over a month and eventually
showed gradual improvement and was discharged home.
His follow up serum POWV IgM analysis by MAC-EIA
was negative (four months after initial presentation).Case 4
A 69-year old male with history of tick bites was evaluated
at a local emergency room for progressive weak-ness,
headaches and fevers. He was diagnosed with a urinary
tract infection and was treated with ciprofloxacin. He
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difficulty ambulating and subjective description of not able
to control the movement of limbs. He presented to the
emergency room again with weakness and a temperature
of 100.4 F. His neurological examination was suggestive of
non-focal generalized weakness but without any loss of
muscle power. Laboratory workup suggested WBC of
12.8 × 103/ul (N = 4.5 – 11.0 x103/ul) and platelets of 90 ×
103/dL (N= 150- 450 × 103/ul)/dL. Initial infectious work
up included Anaplasmosis/Ehrlichia serology for IgG anti-
body (Negative - <1:16), Ehrlichiosis/Anaplasmosis PCR
(negative), West Nile IgM (negative), Babesia microtti IgM
(< 1:16), Babesia microtti PCR (negative), and Lyme ser-
ology (non reactive). He was empirically treated with IV
doxycycline. He continued to have fevers during his admis-
sion. POWV antibody panel was collected from serum.
The patient gradually improved with return of his strength.
He was subsequently discharged to a skilled nursing facility
for further rehabilitation. After discharge from the hospital,
IgM for POWV (MAC-EIA) was subsequently positive
(3 weeks after presentation). He continued to improve
neurologically. However, upon his last follow up at four
months after his hospitalization he continued to have
quadriceps muscle weakness and requires use of arm to
get up from chair and with restriction of range of motion
of lower limb at knee joint due to his weakness.
Discussion
We report a total of four cases of Powassan virus enceph-
alitis. Our first case presented dramatically with seizure
and headaches with negative initial CSF analysis for
POWV. Subsequently his serum analysis was positive for
POWV IgM. He reported complete recovery from POWV
encephalitis. The second case presented with intrapar-
enchymal hemorrhage and was diagnosed via CSF analysis
with positive IgM for POWV. He subsequently had full re-
covery. The same patient also had a positive IgG titer for
the Saint Louis encephalitis virus. Our third patient devel-
oped altered mental status with negative initial CSF ana-
lysis for POWV but his serum analysis was positive for
POWV IgM and on follow up CSF was positive for
POWV. This immunocompromised patient with B-cell
lymphoma had the most severe manifestation of the dis-
ease. Despite his severe neurological deficits, he did im-
prove slowly, but has not returned to baseline
neurological function. Our fourth patient had the least of
the manifestations of POWV encephalitis having mainly
headaches and non-focal weakness. He has almost fully
recovered except for minor residual weakness of the quad-
riceps muscles. His disease was diagnosed with serum
analysis that was positive for POWV IgM with continuous
positivity after a month of presentation on repeat analysis.
All four patients are reported to have significant outdoor
exposure with reported tick bites. Overall, symptomsranged from headaches to seizures and severe neurological
symptoms.
POWV infection is acquired by tick bites usually
Ixodes (Ix.) cookie, Ix. marxi, Ix. spinipalpus and Derma-
centor andersoni ticks [7]. There are 38 mammal species
identified as a domestic reservoir of POWV [4]. There is
a high antibody prevalence of the disease on sero-
logical survey (1 to 4%) suggesting that there are
higher rates of asymptomatic infection. After the tick
bite the incubation period is reported to be around 8
to 34 days [8]. The spectrum of infection varies from
nonspecific prodrome of upper respiratory symptoms
leading to varied neurological involvement such as
headache, dizziness, weakness, and hemiplegia [8].
Gholam et al and a few other researchers have
reported a high case fatality rate of up to 5 to 10%
with high rates of residual neurological dysfunction in
the survivors including hemiplegia, memory impair-
ment, and ophthalmoplegia [5,8-10].
Diagnosis of POWV encephalitis is established by
following guidelines established by Center for disease
control and prevention (CDC) and Council of State
and Territorial Epidemiologists [11]. This specifies
use of clinically compatible disease findings with la-
boratory confirmation of detecting IgM antibody
against POWV in serum or CSF [11]. The serum test
positivity is usually confirmed by Arbovirus Diagnos-
tic Laboratory (ADL) at the CDC for additional test-
ing like demonstration of PRNTs [4]. Reverse
transcriptase polymerase chain reaction in CSF is
also used as a diagnostic modality as reported in re-
cent study from Minnesota [12]. In our study case 1
reported initial negative IgM analysis followed by a
positive IgM analysis with MAC –EIA method. It
does draw our attention to the fact that what may
have caused such a difference. The authors are as-
suming that the variation in the laboratory work may
be the result of either a longer lag phase in appear-
ance of IgM antibody in serum or the second titer
was high likely due to a positive convalescent titer.
At this time we do not have any available research
on time of detection of serum IgM after initial
exposure.
Choi and colleagues recently reported a case of bilat-
eral thalamic hemorrhagic encephalitis from POWV
[13]. The patient reported in their case had resolution of
the hemorrhage on follow up with clinical improvement.
Case 2 reported here had bilateral frontal and temporal
intraparenchymal hemorrhage on presentation and his
clinical status did improve subsequently without radio-
logical improvement after one month. Subsequent CT
brain images after two months showed resolution of
intraparenchymal hemorrhage (Figure 3). As mentioned
in other literature there is no specific preferential area of
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encephalitis.
The disease is gradually making its way from the
northeastern United States to the Midwest United States
[2,4,5]. Though the cases reported here turned out to be
non fatal, the disease has been reported to have a high
case fatality rate [8]. Currently the serum IgM and CSF
IgM tests are the commonly used diagnostic tests for the
POWV detection [11]. The initial positive test from the
state health department is confirmed by further testing
in CDC.
One of the limitation of our study is the use of MAC
–EIA method for the diagnosis of POWV. Most of our
patients with compatible findings underwent sample col-
lection, which was sent to MDOH for detection, and
subsequent confirmation and long term follow up for
resolution of titers. Due to the unavailability of the test
commercially in most of the hospitals our diagnosis abil-
ity relied on testing done following the guidelines of
CDC and we relied on the diagnosis based on what
method the health department choose to diagnose the
disease. In our case 3 the MN DOH used the reverse
transcriptase PCR for the diagnosis of the patient.
There should be a higher clinical suspicion for the de-
tection of POWV infection and that should lead to the
ordering of appropriate diagnostic testing. The current
obstacle to the detection of the disease is lack of clinical
suspicion, and the lack of commercial diagnostic testing
at regional hospitals.
There is no effective vaccine or treatment available for
this clinical entity and the primary focus should be on
prevention of acquiring the disease specifically through
tick bites. Due to the lack of public awareness and lack
of specialized testing with delay in diagnosis, the actual
prevalence of POWV infection may be underreported. It
may be beneficial to have public education to increase
awareness for POWV infections in areas of high endem-
nicity. There should be systemic environmental efforts
to identify the tick-infested areas with the POWV infec-
tion and all efforts should be performed to educate the
population in that area to minimize the exposure.
Conclusion
These four cases in a single year seen in our institution
is the highest disease burden we have seen in the state
of northern Minnesota and North Dakota. The actual
rates of infection may be higher than reported due to
the possibility of missed cases in the community. There
is definitely a high level of exposure to ticks in the Mid-
west due to occupational and recreational exposures in
the warmer months of the year with high risk associated
of acquiring the disease. Our case series shows the im-
portance of bringing this as a public health concern due
to the significant tick exposures in the upper Midwest,which is known to be endemic for certain tick-borne
infections. A larger ecological investigation in upper
Midwest in form of Entomological survey may be helpful
to identify the areas with high infestation for ticks with
POWV. The ecological study can also address the co-
infection rates in the ticks for Borellia burgdorferi, Ana-
plasmosis, and Ehrlichiosis, for which Ixodes is a com-
mon carrier. Information from these investigations can
potentially lead to public awareness regarding POWV
infections.
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